bearish
Samsung Biologics: Regulators Crack Down On Its Accounting
473 Views12 Jul 2018 17:44
After the market close today, the Korean regulators (Financial Services Commission) made a major negative announcement on Samsung Biologics Co.,...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Samsung Biologics: A Temporary Suspension of Shares Trading14 Nov 2018
- The Odd Timing of the Final Rule on Samsung Biologics and Firing of Kim Dong-Yeon & Jang Ha-Sung12 Nov 2018
- Why Is the Moon Administration So Anti-Samsung?18 Jun 2018
- FSC Chairman Speaks on Decision Framework25 May 2018
- Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas01 May 2018
x